Atlanta hand surgeon Dr. John Seiler III on two years operating with a wearable 3D digital surgical microscope, why the shift from hospital to ASC is not reversible, and what it takes to get there.
Partnership expands access to objective brain assessment technology for healthcare providers, hospitals, sports medicine programs, and concussion specialists.
Maker of SurgiSight™, the world’s first wearable surgical microscope, takes top honors in the Healthtech/Biotech track at the Southeast’s largest startup capital summit and Startup World Cup regional qualifier.
Named in BONEZONE as a leading US-based contract manufacturer of calcium phosphates for medical devices, CaP Biomaterials manufactures custom materials found inside FDA-cleared bone void fillers for OEMs, from startups to some of the industry’s largest names. Onno Visser and Keith Orlowski on twenty years of purposeful growth.
Surgeons generate up to 70 percent of a hospital’s revenue, yet three in four report pain and fatigue in the OR. Sabrina Hellstern and Claudia Sodha built noac to protect that revenue and the people who create it, and NATO is already on board.
A RealSpine portfolio built on one platform brings cadaver independent spine training to US programs, with a new modular family and an expanded Deformity line.
The man who helped build a $701M exit to Stryker is now bringing affordable wearable surgical magnification to hospitals, ambulatory surgery centers, and surgeons who’ve been limited by access to microscopy for far too long.
From patient positioning and immobilization to workflow fit and reproducible radiotherapy setups, David Holdford has helped build a company around a simple idea: when clinics can trust the setup, everything works better.
Headsafe’s Chief Strategy & Commercial Officer has built Inc. 5000 companies, navigated exits, and mentored a generation of healthcare leaders. Now he is bringing the most disruptive concussion tool in the U.S. market to every clinic and sideline that needs it.
Some of the most compelling stories in MedTech don’t start in a boardroom. They start with a problem no one is taking seriously enough.
